Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-274918
Filing Date
2024-12-11
Accepted
2024-12-11 09:04:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d904031d424b3.htm 424B3 29686
2 GRAPHIC g904031g1211015249894.jpg GRAPHIC 3479
3 GRAPHIC g904031g1211020047388.jpg GRAPHIC 2573
  Complete submission text file 0001193125-24-274918.txt   39534
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 241540339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)